Astrid Magenau
Garvan Institute of Medical Research, NSW, Australia
Presentations this author is a contributor to:
Temporal proteomic profiling reveals Nidogen-2 as a new stromal co-target in pancreatic cancer (#138)
1:00 PM
Brooke Pereira
Lunch & Poster Viewing (Even Numbers)
SPEAR: A Phase 2, Open-label, Single-arm Monotherapy Trial of Sulfasalazine in Pancreatic Adenocarcinoma – Trial in Progress (#321)
12:45 PM
Omali Pitiyarachchi
Lunch & Poster Viewing (Odd Numbers)